Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 170, pseudogene (RNU6-170P)
- Target
- RNU6-170P
- Molecular classification
- Other (Pseudogene; not an active molecule), Small nuclear RNA pseudogene
01
Overview
RNU6-170P is a pseudogene related to the U6 small nuclear RNA family. Pseudogenes are segments of DNA related to functional genes but have lost protein-coding or RNA-coding ability due to mutations. RNU6-170P contains sequence homology with functional U6 RNA, but lacks splicing activity[3]. U6 snRNA itself is an essential component of the spliceosome, required for pre-mRNA splicing in eukaryotes, but the pseudogene version is not functionally involved in splicing or any known biological process[1][2][3]. For structured biomedical applications, RNU6-170P should not be annotated as a bona fide molecular target, and there is no evidence it plays a functional, druggable, or disease-related role in human biology. For details about the *functional U6 snRNA*, see U6 small nuclear RNA rather than pseudogene entries[1][2][4].
- Other names
- RNU6-170PRNA, U6 small nuclear pseudogene 170
02
Mechanism of action
None (As above.)
03
Biological functions
None (Pseudogenes generally do not have biological function. U6 snRNA is involved in splicing, but pseudogene versions do not participate[3].)
04
Disease associations
None (No documented role in disease; pseudogenes are typically inactive.)
05
Safety considerations
None (Not a drug target.)
06
Interacting drugs
None (No drugs target RNU6-170P. Functional U6 snRNA has not been directly targeted by drugs in therapeutic contexts[1][4].)
07
Biomarkers
None (No evidence supporting use of this pseudogene as biomarker.)
Beyond the preview
Go deeper on RNA, U6 small nuclear 170, pseudogene (RNU6-170P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6 small nuclear 170, pseudogene (RNU6-170P).